India Glycols gets NCLT nod to split into two firms

India Glycols gets NCLT nod to split into two firms. The NCLT has approved the demerger of India Glycols’ biopharma and spirits businesses into two independent entities. This move aims to unlock shareholder value and allow focused growth in each vertical. The final scheme awaits shareholder and regulatory approvals.

📊 STOCKS: INDIAGLYCO | 🏢 SECTOR: Corporate | #MEDIUMIMPACT #CorporateRestructuring